Formulation of fast release glibenclamide liquid and semi-solid matrix filled capsules

Acta Pharmaceutica

Volumn 53, Issue 1, 2003, Pages 57-64

  Galal, Saly ^a   El Massik, Magda ^a   Abdallah, Ossama ^a   Daabis, Nabila ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Capsules; Dissolution; Glibenclamide; Liquid matrix; Semi solid matrix

Indexed keywords

DRUG CARRIER; DRUG VEHICLE; GELUCIRE; GLIBENCLAMIDE; GLYCOL; MACROGOL 6000; MACROGOL DERIVATIVE; SEMIDAONIL;

ANALYTIC METHOD; ARTICLE; CAPSULE FILLING; CHEMISTRY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; DRUG CAPSULE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EGYPT; LIQUID; MICROCAPSULE; QUANTITATIVE ANALYSIS; SOLID; SOLUTION AND SOLUBILITY; SUSPENSION; TABLET; TIME; VEHICLES;

EID: 0037367943     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. D. I. O'Sullivan and W. F. Cashman, Blood glucose variation and clinical response with glibenclamide in diabetes mellitus, Br. Med. J. 2 (1970) 572-574.
2. M. M. Varma, S. B. Jayaswal and J. Singh, In vitro and in vivo evaluation of fast release solid dispersions of glibenclamide, Indian Drugs 29 (1992) 608-611.
3. J. B. Chalk, M. Patterson, M. T. Smith and M. J. Eadie, Correlations between in vitro dissolution, in vivo bioavailability and hypoglycemic effect of oral glibenclamide, Eur. J. Clin. Pharmacol. 31 (1986) 177-182.
4. G. V. Betageri and K. R. Makaria, Characterization of glyburide-polyethylene glycol solid dispersions, Drug Dev. Ind. Pharm. 22 (1996) 731-734.
5. A. S. Geneidi, M. S. Adel and E. Shehata, Preparation and in vitro dissolution characteristics of various fast release solid dispersions of glibenclamide, Can. J. Pharm. Sci. 15 (1980) 78-80.
6. A. S. Geneidi, M. S. Adel and E. Shehata, Enhanced dissolution of glibenclamide from glibenclamide-poloxamer and glibenclamide-PVP coprecipitate, Can. J. Pharm. Sci. 15 (1980) 81-84.
7. G. V. Betageri and K. R. Makaria, Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques, Int. J. Pharm. 126 (1995) 155-160.
8. B. E. Jones, Practical advances in two piece gelatin capsules, Manuf. Chem. 58 (1987) 27-31.
9. A. T. M. Serajuddin, Bioavailability enhancement of poorly soluble drugs by solid dispersion in surface active and self emulsifying vehicles, Bull. Tech. Gattefosse 90 (1997) 91-99.
10. J. M. Kovarik, E. A. Mueller, J. B. Bree, W. Telzloff and K. Klaus, Reduced inter and intra individual variability in cyclosporine pharmacokinetics from a microemulsion formulation, J. Pharm. Sci. 83 (1994) 444-446.
11. Q. M. D. Craig, The physical characterisation of gelucire 50/13, Bull. Tech. Gattefosse 89 (1996) 39-50.
12. British Pharmacopoeia, Her Majesty's Stationary Office, London 1998.
13. The United States Pharmacopoeia, 24, United States Pharmacopoeial Convention, Rockville 2000.
14. H. Emilsson, S. Sjoberg, M. Svedner and I. Christenson, High-performance liquid chromatographic determination of glibenclamide in human plasma and urine, J. Chromatogr. Biomed. Appl. 56 (1986) 93-102.
15. R. K. Chang, K. S. Raghavan and M. A. Hussain, A study of gelatin capsule brittleness: Moisture transfer between the capsule shell and its content, J. Pharm. Sci. 87 (1998) 556-558.
16. E. T. Cole, Liquid filled hard gelatin capsules, Pharm. Technol. 13 (1989) 124-140.
17. P. Roussin and J. P. Laforet, Gelucira 44/14: A high performance system to ennhance bioavailability of poorly water soluble drugs, Bull. Tech. Gattefosse 90 (1997) 51-57.
18. B. J. Aungot, N. Nguyen, N. J. Rogers, S. Rowe, M. Hussain, L. Shum and S. White, Improved oral bioavailability of an HIV protease inhibitor using gelucire 44/14 and labrasol vehicles, Bull. Tech. Gattefosse 87 (1994) 49-54.
19. H. Blume, S. L. Ali and M. Siewert, Pharmaceutical quality of glibenclamide products. A multinational post market comparative study, Drug Dev. Ind. Pharm. 19 (1993) 2713-2741.
20. FDA, Division of bioequivalence study, In vitro dissolution testing for glibenclamide tablets, United States Pharmacopoeial Convention, Rockville 1995.